A vascular endothelial growth factor deficiency characterises scleroderma lung disease.

@article{Santis2012AVE,
  title={A vascular endothelial growth factor deficiency characterises scleroderma lung disease.},
  author={Maria Carmen De Santis and Silvia Laura Bosello and Ettore Capoluongo and Rosanna Inzitari and Giusy Peluso and Paola Lulli and Gaetano Zizzo and Mario Bocci and Barbara Tolusso and Cecilia Zuppi and Massimo Castagnola and Gianfranco Ferraccioli},
  journal={Annals of the rheumatic diseases},
  year={2012},
  volume={71 9},
  pages={
          1461-5
        }
}
OBJECTIVES Vascular endothelial growth factor (VEGF) is thought to play an important role in systemic sclerosis (SSc) pathogenesis. It was found to be upregulated in the serum and in the affected skin of scleroderma patients. However, its involvement in scleroderma lung disease is not clear. This study aimed to evaluate VEGF concentration in the bronchoalveolar lavage fluid (BALF) of scleroderma patients with interstitial lung disease, to correlate the cytokine levels in plasma and in the lung… CONTINUE READING
6
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS